AstraZeneca says U.S. to buy additional 500,000 Evusheld doses -Breaking
© Reuters. FILE PHOTO – The AstraZeneca logo is seen at its North America headquarters, Wilmington, Delaware. U.S.A, 22 March 2021. REUTERS/Rachel Wisniewski
(Reuters) – AstraZeneca, NASDAQ: announced Wednesday that the U.S. government had agreed to buy an additional 500,000 doses Evusheld to treat COVID-19.
Company stated that the deliveries of the drugs were expected to take place in the first quarter in 2022. Further details will be revealed in coming weeks.
Disclaimer: Fusion MediaThis website does not provide accurate and current data. CFDs include stocks, futures, indexes and Forex. Prices are provided not by the exchanges. Market makers provide them. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media does not accept any liability for trade losses that you may incur due to the use of these data.
Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this website’s data including quotes, charts, or buy/sell signal information. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.